Literature DB >> 2040921

Assessment of total energy expenditure in free-living patients with cystic fibrosis.

V Spicher1, M Roulet, Y Schutz.   

Abstract

The increase in resting energy expenditure (REE) reported in patients with cystic fibrosis (CF) does not necessarily imply an increase in total energy expenditure (TEE). In this study REE was assessed with open-circuit indirect calorimetry, and free-living 24-hour TEE with the heart rate method. Thirteen patients with CF, aged 8 to 24 years, with adequate nutritional status and moderately decreased pulmonary function, were studied. They were compared with 13 healthy control subjects matched for gender, age, height, and nutritional status. Resting energy expenditure was higher in patients with CF (1512 +/- 88 kcal/day) than in control subjects (1339 +/- 76 kcal/day; p less than 0.01), whereas free-living 24-hour TEE (2345 +/- 127 kcal/day and 2358 +/- 256 kcal/day, respectively) and net mechanical work efficiency of walking on a treadmill (20.4 +/- 0.7% and 19.8 +/- 0.6%, respectively) were similar. Respiratory quotient was higher in patients with CF than in control subjects at rest (0.834 +/- 0.009 vs 0.797 +/- 0.008; p less than 0.05), and tended to remain so during physical exercise, indicating a higher contribution of carbohydrate oxidation to energy expenditure. We conclude that in free living conditions, patients with CF can compensate for their increase in REE by a reduction in spontaneous physical activities or other yet undefined mechanisms.

Entities:  

Mesh:

Year:  1991        PMID: 2040921     DOI: 10.1016/s0022-3476(05)82196-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  7 in total

1.  Bone mineral content in cystic fibrosis patients: correlation with fat-free mass.

Authors:  F Salamoni; M Roulet; F Gudinchet; M Pilet; D Thiébaud; P Burckhardt
Journal:  Arch Dis Child       Date:  1996-04       Impact factor: 3.791

2.  Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD.

Authors:  E M Baarends; A M Schols; K R Westerterp; E F Wouters
Journal:  Thorax       Date:  1997-09       Impact factor: 9.139

3.  Resting energy expenditure and substrate oxidation rates in cystic fibrosis.

Authors:  I M Bowler; J H Green; S P Wolfe; J M Littlewood
Journal:  Arch Dis Child       Date:  1993-06       Impact factor: 3.791

4.  Adequacy of clinical formulae for estimation of energy requirements in children with cystic fibrosis.

Authors:  J J Reilly; T J Evans; J Wilkinson; J Y Paton
Journal:  Arch Dis Child       Date:  1999-08       Impact factor: 3.791

Review 5.  Nutritional management of cystic fibrosis.

Authors:  A MacDonald
Journal:  Arch Dis Child       Date:  1996-01       Impact factor: 3.791

6.  Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.

Authors:  Thierry Ntimbane; Blandine Comte; Geneviève Mailhot; Yves Berthiaume; Vincent Poitout; Marc Prentki; Rémi Rabasa-Lhoret; Emile Levy
Journal:  Clin Biochem Rev       Date:  2009-11

7.  Gender differences in habitual activity in children with cystic fibrosis.

Authors:  H C Selvadurai; C J Blimkie; P J Cooper; C M Mellis; P P Van Asperen
Journal:  Arch Dis Child       Date:  2004-10       Impact factor: 3.791

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.